COVID-19 Diagnostics and Surveillance

Gain insights into COVID-19 diagnostics and surveillance through this informative webinar featuring expert panelists and opening remarks from Representative Ami Bera. Explore the science behind diagnostic tests, delve into the potential and limitations of serology testing, and understand the necessary actions from Congress and the Administration to advance these efforts. Learn about laboratory capacity, molecular diagnostic test development, FDA Emergency Use Authorization guidance, and the science underlying serology tests. Discover key aspects of COVID-19 diagnosis, including activation periods, US cases, test development, sensitivity, and interpretation. Examine the immune response, antibodies, and the role of antibody testing, as well as current testing availability, performance characteristics, and the concept of protective immunity.

Introduction
What is COVID19
Introducing the Experts
Activation Period
US Cases
Diagnosis
Developing Medical Tests
Sensitivity
Summary
Interpretation
Immune Response
Antibodies
Role of Antibody Testing
Current Testing Available
Performance Characteristics
Sensitivity and Specificity
Positive Predictive Value
Protective Immunity
Conclusion
Questions
Question